TY - JOUR
T1 - Epidemiological trends of imported infectious diseases in Japan
T2 - Analysis of imported 2-year infectious disease registry data
AU - Kutsuna, Satoshi
AU - Asai, Yusuke
AU - Yamamoto, Kei
AU - Shirano, Michinori
AU - Konishi, Keiji
AU - Asaoka, Tomohiro
AU - Yamato, Masaya
AU - Katsuragi, Yukiko
AU - Yamamoto, Yudai
AU - Sahara, Toshinori
AU - Tamiya, Aya
AU - Nakamura-Uchiyama, Fukumi
AU - Sakamoto, Naoya
AU - Kosaka, Atsushi
AU - Washino, Takuya
AU - Hase, Ryota
AU - Mito, Haruki
AU - Kurita, Takashi
AU - Shinohara, Koh
AU - Shimizu, Tsunehiro
AU - Kodama, Fumihiro
AU - Nagasaka, Atsushi
AU - Ogawa, Taku
AU - Kasahara, Kei
AU - Yoshimura, Yukihiro
AU - Tachikawa, Natsuo
AU - Yokota, Kyoko
AU - Yuka Murai, N. S.
AU - Sakamaki, Ippei
AU - Hasegawa, Chihiro
AU - Yoshimi, Yusuke
AU - Toyoda, Kazuhiro
AU - Mitsuhashi, Tatsuro
AU - Ohmagari, Norio
N1 - Publisher Copyright:
© 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases
PY - 2021/4
Y1 - 2021/4
N2 - Introduction: The epidemiology of infectious diseases in Japan remains undefined despite the increasing tourism. GeoSentinel, an epidemiological surveillance system for reporting imported infectious diseases, has only two participating facilities in Japan. Although the number of infectious diseases is reported by the National Institute of Infectious Diseases, there is no detailed clinical information about these cases. Therefore, we established J-RIDA (Japan Registry for Infectious Diseases from Abroad) to clarify the status of imported infectious diseases in Japan and provide detailed information. Methods: J-RIDA was started as a registry of imported infectious diseases. Case registration began in October 2017. Between October 2017 and September 2019, 15 medical institutions participated in this clinical study. The registry collected information about the patient's age, sex, nationality, chief complaint, consultation date, date of onset, whether visit was made to a travel clinic before travel, blood test results (if samples were collected), travel history, and final diagnosis. Results: Of the 3046 cases included in this study, 46.7% to Southeast Asia, 13.0% to Africa, 13.7% to East Asia, 11.5% to South Asia, 7.5% to Europe, 3.8% to Central and South America, 4.6% to North America, 3.9% to Oceania, and 2.8% to Central and west Asia. More than 85% of chief complaints were fever and general symptoms, gastrointestinal symptoms, respiratory symptoms, or dermatologic problems. The most common diseases were travelers’ diarrhea, animal bite, upper respiratory infection, influenza, and dengue fever. Conclusions: We summarized two-year cases registered in Japan's imported infectious disease registry. These results will significantly contribute to the epidemiology in Japan.
AB - Introduction: The epidemiology of infectious diseases in Japan remains undefined despite the increasing tourism. GeoSentinel, an epidemiological surveillance system for reporting imported infectious diseases, has only two participating facilities in Japan. Although the number of infectious diseases is reported by the National Institute of Infectious Diseases, there is no detailed clinical information about these cases. Therefore, we established J-RIDA (Japan Registry for Infectious Diseases from Abroad) to clarify the status of imported infectious diseases in Japan and provide detailed information. Methods: J-RIDA was started as a registry of imported infectious diseases. Case registration began in October 2017. Between October 2017 and September 2019, 15 medical institutions participated in this clinical study. The registry collected information about the patient's age, sex, nationality, chief complaint, consultation date, date of onset, whether visit was made to a travel clinic before travel, blood test results (if samples were collected), travel history, and final diagnosis. Results: Of the 3046 cases included in this study, 46.7% to Southeast Asia, 13.0% to Africa, 13.7% to East Asia, 11.5% to South Asia, 7.5% to Europe, 3.8% to Central and South America, 4.6% to North America, 3.9% to Oceania, and 2.8% to Central and west Asia. More than 85% of chief complaints were fever and general symptoms, gastrointestinal symptoms, respiratory symptoms, or dermatologic problems. The most common diseases were travelers’ diarrhea, animal bite, upper respiratory infection, influenza, and dengue fever. Conclusions: We summarized two-year cases registered in Japan's imported infectious disease registry. These results will significantly contribute to the epidemiology in Japan.
UR - http://www.scopus.com/inward/record.url?scp=85097672392&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85097672392&partnerID=8YFLogxK
U2 - 10.1016/j.jiac.2020.11.028
DO - 10.1016/j.jiac.2020.11.028
M3 - Article
C2 - 33309629
AN - SCOPUS:85097672392
SN - 1341-321X
VL - 27
SP - 632
EP - 638
JO - Journal of Infection and Chemotherapy
JF - Journal of Infection and Chemotherapy
IS - 4
ER -